Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Epidemiology, Management and Outcomes of Atrial Fibrillation Among 30 Million Medicare Subjects of Shanghai, China from 2015 to 2020
27 Pages Posted: 17 Jan 2022
More...
There are 2 versions of this paper
Epidemiology, Management and Outcomes of Atrial Fibrillation Among 30 Million Medicare Subjects of Shanghai, China from 2015 to 2020
Epidemiology, Management and Outcomes of Atrial Fibrillation Among 30 Million Medicare Subjects of Shanghai, China from 2015 to 2020
Abstract
Background: Atrial fibrillation(AF) has become a significant public health concern in China, with population aging and urbanization.
Methods: Data screening was performed for 30,244,930 Medicare subjects in the Shanghai Municipal Health Commission database between 2015 and 2020. Patients diagnosed with AF were identified and further assessed for treatment information and clinical outcomes.
Findings: AF prevalence was 0·88% in adult (>18 years) in Shanghai, which increased with age and reached 6·70% at subjects 80 years and over. AF was more prevalent in women compared with men, which could be attributed to higher AF burden in women over 80 years. Driven by increased prescription of non-vitamin K antagonist oral anticoagulants, anticoagulant use increased from 19.46% in 2015 to 56.57% in 2020. The number of left atrial appendage closure increased from 0.16% in 2015 to 1.23% in 2020. Rhythm control strategy was increasingly adopted, as the use of antiarrhythmic drugs doubled and ablation increased by 21% in 2020 compared to 2015. Compared with men, women were less prone to receive rhythm control treatments, including antiarrhythmics, ablation and cardioversion, but more likely to adopt rate control drugs. During the 5.5 years follow-up, stroke, transient ischemic attack, systemic embolism, bleeding, and myocardial infarction were observed in 6.09%, 5.74%, 1.44%, 5.11% and 8.41% respectively in AF patients.
Interpretation: The burdens of AF and AF-related outcomes in Shanghai are high. Management of AF is markedly improved in recent years, and was not or only slightly impeded by the COVID-19 pandemic. Sex differences are observed in the prevalence, management, and outcomes of AF.
Funding: Shanghai Hospital Development Center, National Natural Science Foundation of China and Shanghai Municipal Science and Technology Commission.
Declaration of Interest: All authors declare no conflicts of interest.
Ethical Approval: This study was approved by the ethics committee of Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University.
Keywords: cardiovascular disease, prevalence, arrhythmia, anticoagulation, ablation, left atrial appendage closure, COVID-19, sex difference
Suggested Citation: Suggested Citation